Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized, double-blind, placebo-controlled trial of PF-03049423 in ischemic stroke
2010-021414-32Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing PF-03049423 with Placebo (2 arms). Primary endpoint: Primary endpoints (Part 1). Started Sep 2010; status: terminated.
02
Drugs
PF-03049423
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2010-021414-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021414-32.